Log In
Print this Print this

mv rOspA LB vaccine

  Manage Alerts
Collapse Summary General Information
Company Baxter International Inc.
DescriptionMultivalent recombinant OspA Lyme borreliosis vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationLyme disease
Indication DetailsPrevent Lyme disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today